Bone Biologics Corp (BBLG) financial statements (2020 and earlier)

Company profile

Business Address 2 BURLINGTON WOODS DRIVE,
BURLINGTON, MA 01803
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
10/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0111130
Cash and cash equivalents0111130
Prepaid expense000000 
Deferred costs    1  
Other undisclosed current assets   0 1 
Total current assets:0111240
Noncurrent Assets
Property, plant and equipment 00000 
Total noncurrent assets: 00000 
TOTAL ASSETS:0111240
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:001000 
Accounts payable00000  
Accrued liabilities     0 
Employee-related liabilities001000 
Interest and dividends payable   0 (0) 
Other undisclosed accounts payable and accrued liabilities     0 
Debt   1   
Deferred compensation liability0000   
Derivative instruments and hedges, liabilities     0 
Due to related parties 9   4 
Other undisclosed current liabilities0  22(0) 
Total current liabilities:1101324 
Noncurrent Liabilities
Long-term debt and lease obligation   664 
Long-term debt, excluding current maturities   664 
Liabilities, other than long-term debt11 8    
Due to related parties11 8    
Total noncurrent liabilities:11 8664 
Other undisclosed liabilities      0
Total liabilities:1210910880
Stockholders' equity
Stockholders' equity attributable to parent, including:(12)(9)(8)(9)(6)(4)(0)
Common stock0000000
Common stock, share subscribed but unissued, subscriptions receivable  2    
Additional paid in capital555549382080
Retained earnings (accumulated deficit)(67)(64)(59)(47)(26)(12)0
Other undisclosed stockholders' equity attributable to parent      (0)
Total stockholders' equity:(12)(9)(8)(9)(6)(4)(0)
TOTAL LIABILITIES AND EQUITY:0111240

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
10/31/2013
Gross profit:1,070      
Operating expenses(2)(3)(3)(18)(12)(3)(0)
Other operating expense, net
(Other Expenses)
     (1) 
Other undisclosed operating income (loss)(1,070)    1 
Operating loss:(2)(3)(3)(18)(12)(3)(0)
Nonoperating expense(1)(2)(4)(3)(2)(1) 
Interest and debt expense(1)(0)(0)(0)(1)(1) 
Other undisclosed income from continuing operations before equity method investments, income taxes  0011 
Loss from continuing operations before equity method investments, income taxes:(4)(4)(7)(21)(14)(4)(0)
Other undisclosed income from continuing operations before income taxes10     
Loss from continuing operations before income taxes:(3)(4)(7)(21)(14)(4)(0)
Income tax expense(0)(0)(0)(0)(0)(0) 
Net loss:(3)(4)(7)(21)(14)(4)(0)
Other undisclosed net loss attributable to parent      (0)
Net loss available to common stockholders, diluted:(3)(4)(7)(21)(14)(4)(0)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
10/31/2013
Net loss:(3)(4)(7)(21)(14)(4)(0)
Comprehensive loss, net of tax, attributable to parent:(3)(4)(7)(21)(14)(4)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: